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Introduction
Inflammatory bowel disease (IBD) is a chronic, relapsing, and remitting gastrointestinal disease characterized by inflammation in the intestine (Strober et al., 2002) . IBD is characterized by two major forms Crohn's disease (CD) and ulcerative colitis (UC). It has been suggested that human IBD is associated with infiltration of the intestinal lamina propria (LP) by mononuclear cells such as macrophages or lymphocytes that over-express NF-jB-regulated target genes, such as the proinflammatory cytokines TNF-a, IL-1b, and IL-6 (Podolsky, 2002) . Murine models of colitis that resemble human IBD provide important tools to develop novel therapeutic strategies for this disease (Strober et al., 2007) . Similar to human IBD, it has been reported that persistent intestinal inflammation in mice results from massive immune cell infiltration, associated with either enhanced or aberrant immunologic responsiveness to the normal gut flora (Singh et al., 2007b) . It has been shown that T cells are key players in tissue injury mediated by both immune and non-immune cells, and occurs in the areas that are heavily infiltrated with activated T cells (Maynard and Weaver, 2009 ).
